cefovecin

01/01/2015 - "It is the first study on in vitro activity of cefovecin against bacterial isolates from cats with lower urinary infections in Istanbul, Turkey."
12/01/2021 - "These findings may aid in selecting species for cefovecin pharmacokinetic research and for empirical treatment of infections caused by susceptible bacteria."
08/01/2015 - "In the absence of additional microbial susceptibility data for alpaca pathogens, the current cefovecin dosage regimen prescribed for dogs (8 mg/kg SC every 14 days) may need to be optimized for the treatment of infections in this species."
01/01/2015 - "Cefovecin is not efficacious for treatment of RGM infections."
02/01/2013 - "Cefovecin has been widely used to treat skin infections in dogs. "

06/01/2008 - "Cefovecin was demonstrated to be an effective and safe treatment for urinary tract infections."
03/01/2007 - "Cefovecin was shown to be an effective and safe treatment for urinary tract infections."
01/01/2015 - "The aim of this study was to determine the bacterial species recovered from 61 cats with lower urinary tract infection (LUTI), and their susceptibility to cefovecin in vitro. "
09/01/2016 - "Perioperative Cefovecin to Reduce the Incidence of Urinary Tract Infection in Dogs Undergoing Hemilaminectomy."
01/01/2015 - "Bacterial species isolated from cats with lower urinary tract infection and their susceptibilities to cefovecin."

02/01/2013 - "pseudintermedius, as well as the in vivo efficacy of cefovecin therapy in dogs with superficial pyoderma caused by S. "
07/01/2007 - "Clinical efficacy and safety of cefovecin in the treatment of canine pyoderma and wound infections."
08/01/2012 - "A good level of evidence was identified supporting the high efficacy of subcutaneously injected cefovecin in superficial pyoderma and for oral amoxicillin-clavulanic acid in deep pyoderma. "
02/01/2013 - "Usefulness of cefovecin disk-diffusion test for predicting mecA gene-containing strains of Staphylococcus pseudintermedius and clinical efficacy of cefovecin in dogs with superficial pyoderma."
02/01/2013 - "To determine the usefulness of an in vitro cefovecin disk-diffusion test in predicting the presence of the mecA gene in Staphylococcus pseudintermedius, as well as the in vivo efficacy of cefovecin therapy in dogs with superficial pyoderma. "

07/15/2012 - "To compare efficacy of amoxicillin-clavulanic acid, cefovecin, and doxycycline in shelter-housed cats with clinical signs of upper respiratory tract disease (URTD). "
07/15/2012 - "Comparison of the efficacy of amoxicillin-clavulanic acid, cefovecin, and doxycycline in the treatment of upper respiratory tract disease in cats housed in an animal shelter."

08/01/2014 - "Cefovecin is thus shown to be effective in vitro against anaerobic bacteria isolated from dogs and cats with periodontal disease. "
08/01/2014 - "In vitro efficacy of cefovecin against anaerobic bacteria isolated from subgingival plaque of dogs and cats with periodontal disease."